Ipamorelin is a synthetic peptide studied for its activity as a growth hormone–releasing peptide (GHRP) through the ghrelin (GHS-R1a) receptor. It has been evaluated in research settings for its role in growth hormone signaling pathways and broader endocrine regulatory mechanisms.